Skip to main navigation Skip to search Skip to main content

CpG-ODN, the TLR9 agonist, attenuates myocardial ischemia/reperfusion injury: Involving activation of PI3K/Akt signaling

  • Quillen College of Medicine
  • The First Affiliated Hospital of Nanjing Medical University
  • East Tennessee State University
  • Animal Model Research Center, Nanjing University

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)96-104
Number of pages9
JournalBiochimica et Biophysica Acta - Molecular Basis of Disease
Volume1832
Issue number1
DOIs
StatePublished - Jan 2013

ASJC Scopus Subject Areas

  • Molecular Medicine
  • Molecular Biology

Keywords

  • Apoptosis
  • Myocardial I/R
  • PI3K/Akt signaling
  • TLR9

Cite this